Form 8-K · Current report
Visa Inc. 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0001403161
- Accession no.
- 0001403161-26-000126
Summary
Visa reported fiscal fourth-quarter net revenue of $12.1 billion, up 13%, and full-year net revenue of $45.9 billion, up 15%, with quarterly GAAP net income of $6.0 billion and full-year GAAP net income of $23.5 billion. Its board increased the quarterly cash dividend 16% to $0.780 per class A share, payable December 1, 2026.
Key points
- Fiscal fourth-quarter GAAP net income was $6.0 billion, or $3.19 per share; non-GAAP net income was $6.6 billion, or $3.48 per share.
- Fiscal full-year GAAP net income was $23.5 billion, or $12.32 per share; non-GAAP net income was $25.3 billion, or $13.27 per share.
- Fiscal fourth-quarter net revenue rose 13% to $12.1 billion, and full-year net revenue rose 15% to $45.9 billion.
- Visa's board declared a quarterly cash dividend of $0.780 per share, a 16% increase, payable December 1, 2026, to holders of record as of November 10, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 27, 2026, Visa Inc. (the "Company") issued an earnings release announcing financial results for the Company's fiscal fourth quarter and full-year ended September 30, 2026. A copy of the earnings release is attached hereto as Exhibit 99.1. All information in the earnings release is furnished but not filed. On October 27, 2026, the Company will host a conference call to discuss its fiscal fourth quarter and full-year 2026 financial results. Item 8.01 Other Events. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.